Carmine N. Stengone Kiora Pharmaceuticals Inc (KPRX) insider trading activity

Carmine N. Stengone is Director of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 1,250 shares of KPRX, which is worth approximately $4,212. The most recent transaction as insider was on Sep 11, 2024, when has been sold 1,250 shares (Common Stock) at a price of $3.68 per share, resulting in proceeds of $4,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.25K

n/a 3M change

n/a 12M change

Total Value Held $4,212

Carmine N. Stengone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 11 2024	BUY Open market or private purchase	$4,600 $3.68 p/Share	1,250 Added 50.0%	1,250 Common Stock

Also insider at

CTNM

Contineum Therapeutics, Inc.

CEO and President

CNS